Alfentanil Versus Remifentanil in Patient-controlled Sedation During

Status Completed

Clinical Trial Summary

Self-administration of propofol and opioid mixture by the patient him- or herself (patient-controlled sedation, PCS) could be successful alternative to the anesthesiologists-managed deep sedation during endoscopic retrograde cholangiopancreatography (ERCP). However, it is not known which opioid would be the most suitable for PCS. The aim of this double-blind study was to compare remifentanil and alfentanil in PCS during ERCP.

Clinical Trial Description

Deep sedation with propofol has been suggested necessary for successful performance of endoscopic retrograde cholangiopancreatography (ERCP).Airway obstruction, hypoventilation and hypoxemia occurs in deeply sedated patients with a high incidence of 12-30%.As a result of frequent hypoxemia events, deep sedation is associated with increased morbidity and mortality.Careful monitoring of vital signs and involving of anesthesia-trained personal are recommended for deeply sedated patients.Self-administration of propofol by the patient him- or herself (patient-controlled sedation, PCS)could be a safer way to use propofol without the presence of an anesthesiologist. In comparison to the anesthesiologists managed deep sedation the main advantages of PCS are reduced consumption of anesthetics and faster recovery.A combination of propofol and different opioids is widely used for PCS however, it is not known which opioid would be the most suitable one. Remifentanil is a potent opioid with ultra short duration of action and usually administered as a constant infusion. The elimination half-life of alfentanil is 8-32 minutes being about 3 times longer, than that of remifentanil. Both opioids have been evaluated previously in PCS but comparative studies are lacking. This study was carried out in order to compare remifentanil and alfentanil in PCS during ERCP in terms of propofol consumption, sedation levels, endoscopist´s and patient's satisfaction. The investigators also sought information about frequency of sedation related complications associated with the different opioids. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01350037
Study type	Interventional
Source	Helsinki University Central Hospital
Contact
Status	Completed
Phase	Phase 4
Start date	June 2009
Completion date	September 2009

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04205058` - Coffee After Pancreatic Surgery	N/A
Completed	`NCT02971579` - A Register on the Quality of ERCP and Training of Endoscopists in Italy
Not yet recruiting	`NCT01900938` - Comparison Between Continuous Infusion and Intermittent Bolus Injection of Propofol for Deep Sedation During ERCP	N/A
Completed	`NCT01427725` - Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency
Not yet recruiting	`NCT05954221` - Red Cell Lysis Buffer Application Versus Conventional Sample Processing in EUS-FNB	N/A
Enrolling by invitation	`NCT02471170` - Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases
Completed	`NCT04705740` - Influence of the Endoscopists and Endoscopic Retrograde CholangioPanceratography
Recruiting	`NCT04259580` - Calgary Registry for Advanced and Therapeutic Endoscopy
Recruiting	`NCT04291651` - UCSF PANC Cyst Registry
Enrolling by invitation	`NCT03234543` - Remote Ischemic Conditioning in Abdominal Surgery	N/A
Completed	`NCT02916199` - Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method	N/A
Completed	`NCT03717298` - Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma	Phase 2
Recruiting	`NCT03334708` - A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Recruiting	`NCT05249400` - Effect of Off-site Assistance on Success Rate of Selective Cannulation During hands-on ERCP Training	N/A
Recruiting	`NCT05824403` - PAncreatic Disease Cohort of TOuLouse
Active, not recruiting	`NCT03269994` - Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?	Phase 3
Enrolling by invitation	`NCT04329039` - Somatostatin Analogues With Perioperative Antibiotics Versus Prolonged Antibiotics	Phase 2/Phase 3
Completed	`NCT03198871` - IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population	Phase 4
Completed	`NCT02337673` - Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography
Completed	`NCT01964430` - Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Alfentanil Versus Remifentanil in Patient-controlled Sedation During Endoscopic Retrograde Cholangiopancreatography (ERCP)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms